Cardiovascular Systems, Inc. is a medical technology company that develops and markets solutions for peripheral and coronary artery diseases in the United States and abroad. It offers various catheter-based platforms that treat different plaque types, peripheral support products, and Diamondback 360 Coronary orbital atherectomy systems for stent delivery in CAD patients. Moreover, Cardiovascular Systems has partnered with Chansu Vascular Technologies to produce novel drug-coated balloons.